iTRAQ-based quantitative analysis of cancer-derived secretory proteome reveals TPM2 as a potential diagnostic biomarker of colorectal cancer.
about
Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinomaTropomyosin isoform Tpm2.1 regulates collective and amoeboid cell migration and cell aggregation in breast epithelial cells.Successful identification of a predictive biomarker for lymph node metastasis in colorectal cancer using a proteomic approach.
P2860
iTRAQ-based quantitative analysis of cancer-derived secretory proteome reveals TPM2 as a potential diagnostic biomarker of colorectal cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
iTRAQ-based quantitative analy ...... iomarker of colorectal cancer.
@en
type
label
iTRAQ-based quantitative analy ...... iomarker of colorectal cancer.
@en
prefLabel
iTRAQ-based quantitative analy ...... iomarker of colorectal cancer.
@en
P2093
P2860
P1476
iTRAQ-based quantitative analy ...... iomarker of colorectal cancer.
@en
P2093
Hongying Wang
Xinxin Shao
P2860
P2888
P304
P356
10.1007/S11684-016-0453-Z
P577
2016-06-09T00:00:00Z
P6179
1001300131